Tissue Engineering to Revolutionize Dental Bone Grafting.
A $90 million investment opportunity by 2019.
Recap
• Bone grafts are widely used to counter
bone resorption and bone defects and
to restore aesthetics and full function.
• $1B industry this year, 14% y/y growth
• Autologous bone graft is the GOLD
standard of the industry. Access to
autologous graft is almost non-existent.
• Device to convert extracted teeth into
highest quality autologous bone graft.
The product
It’s simple for the dental assistant*
* Preparing the graft is typically done by the dental assistant
Amit Binderman, CEO
I
(201) 286-7436
I
amit@KometaBio.com
I
www.kometabio.com
Value propositions
Level of care
Revenue enhancement
Cost reduction
•
•
•
•
•
• Increase revenue off
tooth extraction by
offering an on-the-spot
grafting (socket
preservation
procedure). $400-$500
additional revenue per
extraction.
• Saving of at least one
check up due to fast
healing. This translates
into major savings for
the practice.
• Saving on bone graft
since the consumable is
cheaper than any graft
on the market.
Highest aesthetics
Quick time to heal
Less pain
Best quality graft
Long term bone mgmt.
Typical Tooth Extraction at the GP
Dr. Jim
Dr. Evette
Tooth extraction cost to patient
$200
$650
Anesthesia
$30
$30
Graft material for socket preservation
$50
Membrane
$25
Total Cost
$30
$105
Profit
$170
$545
Time difference
Quality of care
+25 minutes
Mediocre
High
Aesthetics
Low
High
Future readiness for implant prosthetics
Low
High
* 180,000 practicing dentists in the USA pulling 20 million teeth per year.
What did we achieve since June?
•
•
•
•
Completed migrating the company to the USA
Immobilizing and training Benco Dental, and Burkhart Dental.
Bringing Patterson on board, as a nationwide dealer.
Added AdinMexico as our Mexico based dealer, as well as an
additional dealer in Eastern Europe.
• Added 4 additional key opinion leaders that are supporting us
in professional venues
• Exhibited and presented in all key conferences in the USA.
• Applied for national phase patents in 6 key geographies.
Financial position
Financials
Revenue
Expenditures
Net
(A) – actual
2013 (A)
2014 (A)
2015 (E)
2016 (F)
2017 (F)
2018 (F)
44,000
235,300
650,500
2,300,000
7,700,000
12,375,000
202,250
180,530
480,000
1,420,067
3,363,804
4,361,611
(158,250)
54,770
170,500
879,933
4,336,196
8,013,389
(E) – estimate
(F) - forecast
Budget for 2016
•
•
•
•
Item
Budget
SG&A
240,000
Marketing
128,000
Regulatory, Legal and IP
75,000
Manufacturing
25,000
Total
498,000
Complete CE
FDA enhancements
Manufacturing changes
Marketing manager
•
•
•
•
•
Expansion to Europe - Resellers
Distribution in Europe
Logistics management
Partnership expansions
R&D for additional products